Centiva Capital »

Castle Biosciences shares owned by Centiva Capital

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Centiva Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $271k 13k 21.58

More positions owned by Centiva Capital

Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Ishares Tr National Mun Etf (MUB)
Ishares Tr 1 3 Yr Treas Bd Call Option (SHY)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)
stock
Simon Property Call Option (SPG)
Agnc Invt Corp Com reit Call Option (AGNC)
Advanced Micro Devices (AMD)
Citigroup Com New Call Option (C)

View all positions for Centiva Capital

Top funds holding Castle Biosciences

Daniel D. Thurber
Principal Financial Group
Vanguard Group
Bellevue Group
Deerfield Management Company
Portolan Capital Management
Millennium Management
Dimensional Fund Advisors
Kornitzer Capital Management
Palisade Capital Management
Jacobs Levy Equity Management
Citadel Advisors
New York State Common Retirement Fund
Charles Schwab Investment Management
Banque Pictet & Cie Sa

View all funds holding Castle Biosciences